Tykerb 250mg Tablet – Lapatinib 250mg for Breast Cancer
Tykerb 250mg Tablet is a targeted anti-cancer prescription medicine containing Lapatinib 250mg, manufactured by Novartis. It is a tyrosine kinase inhibitor used, alone or in combination with other medicines, to treat advanced-stage HER2-positive breast cancer under specialist oncology supervision.
Key Features
- Contains Lapatinib 250mg, a HER2/EGFR tyrosine kinase inhibitor
- Used in the treatment of advanced breast cancer
- May be used alone or combined with chemotherapy
- Manufactured by Novartis
- Prescription-only (Rx) oncology medicine, bottle of 30 tablets
Composition
- Lapatinib – 250mg
Uses & Benefits
- Treatment of HER2-positive advanced or metastatic breast cancer
- Blocks HER2 and EGFR receptor signalling that drives cancer cell growth
- Helps relieve symptoms such as breast lumps or nipple discharge
- Slows tumour growth and inhibits multiplication of cancer cells
Directions for Use
- Take strictly in the dose and duration advised by your oncologist
- Swallow the tablet whole; do not chew, crush or break it
- Take on an empty stomach, at least 1 hour before or 2 hours after a meal
- Continue treatment for the full duration even if benefits take weeks to appear
Precautions
- To be sold strictly on the prescription of a Registered Medical Practitioner
- Regular blood pressure and liver function monitoring may be required
- May cause severe diarrhoea – stay well hydrated and inform your doctor
- Report severe headache, confusion, vision changes, nausea or vomiting promptly
- Common side effects include nausea, headache, back pain and breathing difficulty
- Not recommended during pregnancy or breastfeeding; use effective contraception
- Discuss all other medicines you take, as interactions are possible
Storage
- Store below 30°C in a cool, dry place away from direct sunlight
- Keep out of reach and sight of children
Disclaimer: This product is a prescription oncology medicine. The information provided is for general awareness only and does not substitute professional medical advice. Please consult a Registered Medical Practitioner/oncologist before use.














Reviews
There are no reviews yet.